🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Advanced Chronic Myeloid Leukemia

Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAML NCT05584761Phase 1, Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: unrelated umbilical cord blood Evaluation of Advanced Practice Nurse's Management of Patients With Chronic Myeloid Leukemia NCT06082804NA1 site📍 Avignon Centre Hospitalier Henri Duffaut - Avignon · Tests: APN and medical management, Medical management, Quality of life assessment, Treatment compliance assessment A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) NCT06950034Phase 17 sites📍 Stanford📍 Tampa📍 Boston Solu Therapeutics, Inc · Tests: STX-0712 Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia NCT07033598Phase 26 sites📍 Tampa📍 Atlanta📍 Rochester Theradex · Tests: Pacritinib, Hydroxyurea Quality of Life-Guided Transfusion in Refractory MDS or AML NCT07328191NA1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Red blood cell transfusions based on EQ-5D-5L questionnaire Study to Evaluate the Safety and Tolerability of EP0042 NCT04581512Phase 1, Phase 26 sites📍 Perth📍 Amsterdam📍 Rotterdam Ellipses Pharma · Tests: EP0042, Venetoclax, Azacitidine (AZA) (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis NCT04996875Phase 242 sites📍 Birmingham📍 Phoenix📍 Duarte Cogent Biosciences, Inc. · Tests: bezuclastinib A Phase I Study of Decitabine, Lisaftoclax, and Olverembatinib in Patients With Advanced Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Myeloid Leukemia NCT06401603Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Decitabine, Listaftoclax, Olverembatinib Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia NCT06523556Phase 1, Phase 21 site📍 Columbus Uma Borate · Tests: Axatilimab, Azacitidine, Biospecimen Collection, Bone Marrow Aspiration and Biopsy, Survey Administration
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy